IGIván García Gómez

Iván García Gómez

*This is an algorithmically generated author record based on publicly available information.

Iván García Gómez has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pulmonary embolism or a fatal mimic? Wall-eclipsing sign and metastatic tissue diagnosis in pulmonary artery intimal sarcoma: a case report

    by Alexis Vallejos Barrientos, Kevin Lévano Carpio, Rolando Chapilliquen Chuyes, Iván García Gómez, Germán Salazar Aldea, Walter Alarco León

    Background: Pulmonary artery intimal sarcoma is a rare, aggressive malignancy that may mimic chronic pulmonary infection and chronic thromboembolic disease. This case highlights the need to reconsider a thromboembolic diagnosis when pulmonary arterial obstruction persists despite anticoagulation and is associated with the wall-eclipsing sign and progressive right ventricular failure. Case summary: A 50-year-old woman presented with 3 months of intermittent haemoptysis and progressive dyspnoea. Initial evaluation suggested chronic infectious lung disease; however, transthoracic echocardiography identified a mass involving the main pulmonary artery. Computed tomography pulmonary angiography was initially interpreted as chronic pulmonary thromboembolism, and anticoagulation was initiated. Shortly thereafter, life-threatening haemoptysis required high-flow nasal oxygen therapy, transfusion of four units of packed red blood cells, and vasopressor support. Follow-up imaging showed persistent pulmonary arterial obstruction with progressive right ventricular failure. Repeat computed tomography pulmonary angiography demonstrated an infiltrative pulmonary artery mass with intrinsic enhancement, left atrial extension, and the wall-eclipsing sign. Breast nodules and axillary lymphadenopathy prompted biopsy of an accessible breast lesion, which revealed a high-grade spindle-cell neoplasm with CD31 and ERG expression, supporting angiosarcomatous differentiation, together with nuclear MDM2 immunoreactivity. Fluorescence in situ hybridization demonstrated MDM2 gene amplification in the breast biopsy, supporting the integrated diagnosis of pulmonary artery intimal sarcoma with angiosarcomatous differentiation and breast metastasis. Discussion: This case highlights the need to reconsider chronic thromboembolic disease when pulmonary arterial obstruction persists despite anticoagulation, particularly in the presence of the wall-eclipsing sign. Metastatic tissue sampling may establish the diagnosis while avoiding high-risk intravascular biopsy.

  • Open Access

    Cuando el betabloqueador revela el diagnóstico: feocromocitoma simulando síndrome coronario agudo: reporte de caso

    by Iván García-Gómez, María Angélica-Medrano, David Galvez-Caballero, Alexis Vallejos-Barrientos, Luis Eslava-Galvez

    El feocromocitoma es un tumor neuroendocrino productor de catecolaminas cuya presentación clínica puede simular un síndrome coronario agudo y representar un reto diagnóstico en la cardiología clínica. Presentamos el caso de un varón de 63 años con dolor precordial intermitente, hipertensión paroxística e incremento leve de troponinas. Fue referido a nuestra institución con diagnóstico de síndrome coronario agudo. Los electrocardiogramas de ingreso no evidenciaron signos de isquemia aguda; el ecocardiograma transtorácico no mostró trastornos segmentarios de motilidad. Se propuso una estratificación isquémica no invasiva. Previo a la angiografía coronaria por tomografía computarizada (CCTA), se administró propranolol, tras lo cual el paciente desarrolló crisis hipertensiva y dolor precordial. El mismo episodio se presentó luego de una segunda dosis de betabloqueador. La CCTA no identificó estenosis coronarias significativas. Ante la sospecha de feocromocitoma, la tomografía abdominal con contraste mostró un nódulo suprarrenal izquierdo y en la orina se identificaron metanefrinas elevadas. Se realizó una adrenalectomía y la histopatología confirmó un feocromocitoma benigno. El paciente evolucionó favorablemente, asintomático hasta la fecha.

  • Open Access

    Bias control in clinical trials: masking or blinding

    by José Kelvin Galvez-Olortegui, Jaime Gonzales-Saldaña, Iván Garcia-Gomez, Isabel Silva-Ocas, Jessica Gutierrez-Arana, Tomas Galvez-Olortegui, Yudy Cley Condor-Rojas